Therefore, two strategies among others were suggested against hypercholesterolemia: inhibition of intracellular cholesterol biosynthesis by statins and a variety of anti-PCSK9 therapeutic modalities [4, 5, 9–11]. Here, PCSK9 is linked to familial hypercholesterolemia.